F&P Deimos Nasal Pillows Mask
DeviceInvestigative Nasal Pillows Mask to be used for OSA therapy
Other names: Deimos Mask
NCT Number: NCT02894242
This investigation is designed to evaluate the performance as well as the patients overall acceptance of the mask.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Fisher and Paykel Healthcare, Auckland, New Zealand
A minimum of 20 OSA participants who currently use a nasal pillows mask will be recruited for the trial. Participant will be on the trial for three weeks - first week will be a collection of Positive Airway Pressure (PAP) baseline data on the participant's usual mask. The participant will then use the trial mask in-home for 2 weeks. There is also an option of a two month extension if the participant wish to continue on the trial mask.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Investigative Nasal Pillows Mask to be used for OSA therapy
Other names: Deimos Mask
Time frame: 2 weeks in home
Subjective questionnaire
Time frame: 2 weeks in home
Subjective questionnaire
Time frame: 2 weeks in home
Obtained from participants' device
Fisher and Paykel Healthcare
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03964376
Apnea, Dyssomnias
Toronto, Ontario, Canada
View Trial DetailsNCT03718858
Apnea, Dyssomnias
Toronto, ON Ontario, Canada
View Trial DetailsNCT01918007
Apnea, Dyssomnias
Athens, Greece
View Trial DetailsNCT03226652
Apnea, Cardiovascular Diseases
London, United Kingdom
View Trial Details